NR1I2 and hepatocellular carcinoma: The pregnane X receptor (PXR), a member of the nuclear receptor superfamily, regulates genes involved in xenobiotic metabolism and drug resistance, such as CYP450 and ATP-binding cassette transporters [381], and studies have shown that sorafenib therapy triggers PXR expression in HCC cells, resulting in increased drug clearance and reduced sensitivity [382].